A new Northwestern Medicine study has identified a trigger of some fibrotic diseases and an experimental compound to treat it.
Drinking coffee is associated with a lower risk of death, according to a large study published in JAMA Internal Medicine.
Two drugs that target mutations in leukemia showed encouraging results, according to recent clinical trials.
Northwestern Medicine scientists have discovered the activation mechanism of a calcium channel, providing new insights for future drug development targeting this calcium signaling pathway.
Feinberg scientists are confronting significant, global challenges — from antimicrobial resistance to HIV — through collaborative, cutting-edge basic science and clinical research within the Division of Infectious Diseases.
An existing drug significantly lowered the risk of metastasis or death when used in men with non-metastatic castrate-resistant prostate cancer and a rising PSA level, according to a study published in the New England Journal of Medicine.
Novel research is changing the way we approach healthcare for mothers and their babies. Read the feature in Northwestern Medicine magazine.
Middle-aged men with erectile dysfunction had a greater chance of experiencing cardiovascular events, according to a research letter published in Circulation.
Treating mice with isradipine, a calcium channel blocker, prevented formation of toxic compounds that can cause Parkinson’s disease symptoms, according to a recent Northwestern Medicine study.